LIMN

Liminatus Pharma, Inc.

NASDAQ · Biotechnology mkt cap 5,681,765
High confidence Medium Low Unknown
Line thickness = strength · colour = confidence

Drawing the 24 strongest — 43 further edges are not on this diagram

Relationships 24 of 67

Capped at 24 strongest — 43 not shown

Co-mentioned in news 5

Both companies were named in the same news article. Co-mention is adjacency, not a business relationship.

MSTR Strategy Inc Graph ›
0.00 conf 0.90
ONDS Ondas Inc. Graph ›
0.00 conf 0.90
TIRX TIAN RUIXIANG HOLDINGS LTD Graph ›
0.00 conf 0.90
TNONW Tenon Medical, Inc. Graph ›
0.00 conf 0.90
ZCMD Zhongchao Inc. Graph ›
0.00 conf 0.90
Peer similarity 19

Computed by us from market capitalisation, earnings cadence, dividend frequency and exchange. Not a reported relationship.

PCSA Processa Pharmaceuticals, Inc. Graph ›
1.00 conf 1.00
PULM Pulmatrix, Inc. Graph ›
1.00 conf 1.00
CVKD Cadrenal Therapeutics, Inc. Graph ›
1.00 conf 1.00
XTLB XTL BIOPHARMACEUTICALS LTD Graph ›
1.00 conf 1.00
ACXP Acurx Pharmaceuticals, Inc. Graph ›
0.99 conf 1.00
BRTX BioRestorative Therapies, Inc. Graph ›
0.99 conf 1.00
ADTX Aditxt, Inc. Graph ›
0.98 conf 1.00
ELAB PMGC Holdings Inc. Graph ›
0.98 conf 1.00
TCRT Alaunos Therapeutics, Inc. Graph ›
0.98 conf 1.00
MBIO MUSTANG BIO, INC. Graph ›
0.98 conf 1.00
VIVS VivoSim Labs, INC. Graph ›
0.97 conf 1.00
EVGN Evogene Ltd. Graph ›
0.97 conf 1.00
CALC CalciMedica, Inc. Graph ›
0.96 conf 1.00
VTGN Vistagen Therapeutics, Inc. Graph ›
0.95 conf 1.00
PPBT PURPLE BIOTECH LTD. Graph ›
0.94 conf 1.00
RNAZ Transcode Therapeutics, Inc. Graph ›
0.93 conf 1.00
CTXR Citius Pharmaceuticals, Inc. Graph ›
0.92 conf 1.00
APM Aptorum Group Ltd Graph ›
0.82 conf 1.00
TOVX Theriva Biologics, Inc. Graph ›
0.75 conf 1.00

Edge strength is relative to the strongest edge in this view and is not comparable across views. Confidence is the mean confidence of the active evidence behind an edge, on an absolute scale. Peer-similarity edges are computed by us and are not a reported relationship; co-mention edges record that two companies appeared in the same article, which is adjacency rather than a business connection.